NATURAL-KILLER/T-CELL LYMPHOMA (NKTCL) SUSCEPTIBILITY PREDICTION, DIAGNOSIS AND THERAPY
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Oct 15, 2015
app pub date -
Nov 26, 2012
filing date -
Nov 25, 2011
priority date (Note) -
Abandoned
status (Latency Note)
![]() |
A preliminary load of PAIR data current through [] has been loaded. Any more recent PAIR data will be loaded within twenty-four hours. |
PAIR data current through []
A preliminary load of cached data will be loaded soon.
Any more recent PAIR data will be loaded within twenty-four hours.
![]() |
Next PAIR Update Scheduled on [ ] |

Importance

US Family Size
|
Non-US Coverage
|
Abstract
Natural-Killer T-Cell Lymphoma (NKTCL) susceptibility prediction, diagnosis and therapy. The invention relates to a method for predicting Natural Killer T-cell Lymphoma (NKTCL) susceptibility and/or diagnosing NKTCL in a subject comprising testing for JAK mutations. The invention also relates to a method of screening for candidate agents capable of treating NKTCL using a cell line comprising at least one JAK mutation. The invention includes an NKTCL animal model comprising at least one JAK mutation. The invention also includes JAK inhibitors for treating NKTCL.
First Claim
all claims..Other Claims data not available
Family
Country | kind | publication No. | Filing Date | Type | Sub-Type |
---|---|---|---|---|---|
JP | A | JP2015505669 | Nov 26, 2012 | Patent | Application |
Type : Patent Sub-Type : Application | |||||
Published unexamined patent application | ナチュラルキラー/T細胞リンパ腫(NKTCL)の感受性予測、診断および治療 | Feb 26, 2015 | |||
SG | A | SG10201605729T | Nov 26, 2012 | Patent | Grant |
Type : Patent Sub-Type : Grant | |||||
UK PATENTS REGISTERED | NATURAL-KILLER/T-CELL LYMPHOMA (NKTCL) SUSCEPTIBILITY PREDICTION, DIAGNOSIS AND THERAPY | Aug 30, 2016 | |||
EP | B1 | EP2782562 | Nov 26, 2012 | Patent | Grant |
Type : Patent Sub-Type : Grant | |||||
Patent | NATURAL-KILLER/T-CELL LYMPHOMA (NKTCL) SUSCEPTIBILITY PREDICTION, DIAGNOSIS AND THERAPY | Dec 21, 2016 | |||
SG | A | SG11201402611W | Nov 26, 2012 | Patent | Grant |
Type : Patent Sub-Type : Grant | |||||
UK PATENTS REGISTERED | NATURAL-KILLER/T-CELL LYMPHOMA (NKTCL) SUSCEPTIBILITY PREDICTION, DIAGNOSIS AND THERAPY | Jun 27, 2014 | |||
WO | A2 | WO2013077814 | Nov 26, 2012 | Patent | Application |
Type : Patent Sub-Type : Application | |||||
INTERNATIONAL APPLICATION PUBLISHED WITHOUT INTERNATIONAL SEARCH REPORT or INTERNATIONAL APPLICATION PUBLISHED WITH DECLARATION UNDER ARTICLE 17 (2) (A) | NATURAL-KILLER/T-CELL LYMPHOMA (NKTCL) SUSCEPTIBILITY PREDICTION, DIAGNOSIS AND THERAPY | May 30, 2013 | |||
CN | B | CN104220051 | Nov 26, 2012 | Patent | Grant |
Type : Patent Sub-Type : Grant | |||||
GRANTED PATENT FOR INVENTION | Natural-killer/T-cell lymphoma (NKTCL) susceptibility prediction, diagnosis and therapy | Apr 19, 2017 | |||
IN | A | IN2014CN04746 | Jun 24, 2014 | Patent | Grant |
Type : Patent Sub-Type : Grant | |||||
PATENT OR PATENT OF ADDITION | Natural killer/t cell lymphoma (nktcl) susceptibility prediction diagnosis and therapy | Sep 18, 2015 | |||
US | B2 | US10378062 | Jun 06, 2016 | Patent | Grant |
Type : Patent Sub-Type : Grant | |||||
GRANTED PATENT AS SECOND PUBLICATION | Natural-killer/T-cell lymphoma (NKTCL) susceptibility prediction, diagnosis and therapy | Aug 13, 2019 |
- 15 United States
- 10 France
- 8 Japan
- 7 China
- 5 Korea
- 2 Other
Patent Owner(s)
Patent Owner | Address | |
---|---|---|
SINGAPORE HEALTH SERVICES PTE LTD | 31 HOSPITAL AVENUE #03-03 BOWYER BLOCK C SINGAPORE 168753 |
International Classification(s)

- 2012 Application Filing Year
- A61K Class
- 11964 Applications Filed
- 9694 Patents Issued To-Date
- 81.03 % Issued To-Date
Inventor(s)
Inventor Name | Address | # of filed Patents | Total Citations |
---|---|---|---|
Lim, Soon Thye | Singapore, SG | 3 | 0 |
# of filed Patents : 3 Total Citations : 0 | |||
Teh, Bin Tean | Singapore, SG | 10 | 54 |
# of filed Patents : 10 Total Citations : 54 |
Cited Art Landscape
- No Cited Art to Display

Patent Citation Ranking
- 0 Citation Count
- A61K Class
- 0 % this patent is cited more than
- 10 Age
Forward Cite Landscape
- No Forward Cites to Display

Maintenance Fees
Fee | Large entity fee | small entity fee | micro entity fee | due date |
---|---|---|---|---|
11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Apr 15, 2027 |
Fee | Large entity fee | small entity fee | micro entity fee |
---|---|---|---|
Surcharge - 11.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
Surcharge after expiration - Late payment is unavoidable | $700.00 | $350.00 | $175.00 |
Surcharge after expiration - Late payment is unintentional | $1,640.00 | $820.00 | $410.00 |
Full Text

Legal Events
- No Legal Status data available.

Matter Detail

Renewals Detail
